Plain-English translation of NCT06722807 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new surgical approach called clampless, sutureless partial nephrectomy for treating kidney cancer. In this procedure, surgeons remove a cancerous tumor from your kidney using robotic assistance, but without clamping off blood flow to the kidney and without using formal stitches to close the area. The goal is to preserve as much healthy kidney function as possible.
Current kidney cancer surgery often involves clamping blood vessels and stitching the kidney back together, both of which can harm kidney function over time. This trial exists to see whether the new surgical approach is safe and effective, and whether it can become a standard option for more patients who need kidney cancer treatment.
You would undergo a robotic-assisted partial nephrectomy surgery performed by a urologic surgeon at University of Florida. The surgeon would remove your kidney tumor using the new clampless, sutureless technique. You would have standard pre-surgery testing and post-surgery follow-up care to monitor your recovery and kidney function over time.
AI-generated summary from trial data · Aug 1, 2026 · Not medical advice
United States